This attribute is especially engaging in targets for several neurodegenerative diseases involving the toxic build-up of proteins, such as tau, mutant huntingtin, etc. In addition, there are also efforts to develop TPDs for inflammation, immunity-associated diseases, and viral infection. Here, MAPT is linked to neurodegenerative disease.